NMNAT1 and respiratory distress syndrome in premature infants: These findings establish oxidative DNA damage as a key driver of PR degeneration in the Nmnat1<sup>V9M/V9M</sup> model and highlight NAC's potential as a therapeutic strategy for NMNAT1-associated IRD and potentially other IRDs in which oxidative DNA damage contributes to disease pathogenesis.